Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. Rüdiger, C. Kropf, G. Schmid-Bindert, T. Wibmer, M. Lanzinger, K. Stoiber, J. Blanta, W. Rottbauer, C. Schumann (Ulm, Mannheim, Germany). Cetuximab maintenance therapy – How long should we proceed? A case report. Eur Respir J 2011; 38: Suppl. 55, 2777

Member's Comments

No comment yet.

Related content which might interest you: Clinical predictors for long-term benefit of cetuximab maintenance therapy – Single center subanalysis of the GEMTAX IV trial Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients Year: 2011 Spontaneous pneumothorax – when, why, how? Source: Annual Congress 2009 - Pleural and parenchymal diseases Year: 2009 Monitoring of efficacy of therapy with monoclonal antibodies – Omalizumab – Using the Recovery-ELISA Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Reimbursed smoking cessation – can we hope for more? One year expertise report Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation Year: 2009 Patients‘ knowledge about inhalation therapy in pulmology – One year after intervention Source: Annual Congress 2011 - Medical education Year: 2011 Why are we so poor at following guidelines? – A detailed analysis of a bronchiolitis pathway and its implementation Source: Annual Congress 2010 - Paediatric epidemiology: infection, prematurity and congenital abnormalities Year: 2010 Hemoptysis: Causes, interventions and outcomes – Indian single centre experience Source: Annual Congress 2012 - New insights in the clinical management of lung diseases Year: 2012 Long term inhalatory therapy in asthma – Achieving control of the disease Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Smoking assessment & treatment in hospital: Are we providing ‘right care‘ and/or missing cannabis-smoking? Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment Year: 2011 Ways to shorten the lung clearance index measurement ΙΙ – How long to wash? Source: Annual Congress 2012 - New developments in paediatric respiratory physiology Year: 2012 Drug interaction in tuberculosis treatment – The role of pharmacists Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 Triple 0 – A new respiratory syndrome? Source: Annual Congress 2012 - Advanced experience with long-term noninvasive ventilation and late-breaking abstracts Year: 2012 Know it, check it, treat it – COPD consumer mobilisation campaign. A pilot study Source: Annual Congress 2011 - Quality of diagnosis and assessment in primary care Year: 2011 Evaluation of difficult asthma – a single centre experience Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Cryptogenic organising pneumonia – clarithromycin treatment – factors influencing treatment results and relapses Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009 Pulmonary rehabilitation in advanced lung cancer patients during chemotherapy – Preliminary report Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012 Late Breaking Abstract: Inhalation technique errors and education effects in the group of patients using Aerolizer® – The real life study Source: Annual Congress 2010 - Medical education: methodology Year: 2010 How should we investigate the child with difficult asthma – Is there any evidence? Source: Annual Congress 2010 - Quality of life, asthma control and monitoring childhood asthma Year: 2010 EGFR – a useful biomarker? Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009